LAPDYA: Longitudinal Assessment of Post-concussion Driving in Young Adults

Sponsor
University of Georgia (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05942638
Collaborator
Emory University (Other), University of Kansas (Other), Shepherd Center, Atlanta GA (Other)
1,000
58

Study Details

Study Description

Brief Summary

Upwards of 3.8 million concussions occur annually in the United States. Driving is a highly complicated activity that requires visual, motor, and cognitive skills, which are commonly impaired after concussion. Yet, the time course of post-concussion driving impairment has not been characterized. There is a critical need to 1) determine when concussed individuals should return to driving and 2) identify the key concussion assessment predictors of readiness to return to driving. In the absence of formal recommendations, impaired concussed drivers are at risk to themselves and others on the road.

The first specific aim is to compare simulated driving between concussed individuals and non-concussed yoked matched controls across five longitudinal timepoints (pre-injury baseline, day 2, day 4, asymptomatic, and unrestricted medical clearance) and daily naturalistic driving from day 2 to day 9.

Driving recommendations must be appropriate and necessitated by concussion impairments, since excessively strict recommendations wrongfully strip concussed patients of their independence and may dissuade individuals from seeking medical care. The second specific aim is to identify widely used concussion assessment outcomes that predict simulated driving performance among concussed individuals throughout concussion recovery.

To address these aims, 100 concussed and 100 yoked matched control young adult college athletes will complete a simulated driving assessment and a robust concussion assessment battery at pre-injury baseline, day 2, day 4, asymptomatic, and unrestricted medical clearance. Naturalistic driving (measured with in-car global positioning systems) will be captured from day 2 to day 9 (7 days total).

This study will determine the acute and subacute time course of post-concussion driving impairment and determine key predictors of post-concussion driving performance. Results from this innovative approach will have a broad and positive impact that will improve the safety of both concussed individuals and the general population, guide the practices of health professionals, inform the future work of researchers, and substantiate the work of policy-makers by providing evidence-based recommendations for managing post-concussion driving.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    1000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Longitudinal Assessment of Post-concussion Driving in Young Adults
    Anticipated Study Start Date :
    Aug 1, 2023
    Anticipated Primary Completion Date :
    Jun 1, 2028
    Anticipated Study Completion Date :
    Jun 1, 2028

    Arms and Interventions

    Arm Intervention/Treatment
    Concussion Group

    Control Group

    Outcome Measures

    Primary Outcome Measures

    1. Centerline Crossings (count) [Pre-injury baseline]

      Count of centerline crossings during a custom STISIM3 driving simulation scenario

    2. Centerline Crossings (count) [Day 2]

      Count of centerline crossings during a custom STISIM3 driving simulation scenario

    3. Centerline Crossings (count) [Day 4]

      Count of centerline crossings during a custom STISIM3 driving simulation scenario

    4. Centerline Crossings (count) [Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)]

      Count of centerline crossings during a custom STISIM3 driving simulation scenario

    5. Centerline Crossings (count) [Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)]

      Count of centerline crossings during a custom STISIM3 driving simulation scenario

    6. Road edge excursions (count) [Pre-injury baseline]

      Count of road edge excursions during a custom STISIM3 driving simulation scenario

    7. Road edge excursions (count) [Day 2]

      Count of road edge excursions during a custom STISIM3 driving simulation scenario

    8. Road edge excursions (count) [Day 4]

      Count of road edge excursions during a custom STISIM3 driving simulation scenario

    9. Road edge excursions (count) [Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)]

      Count of road edge excursions during a custom STISIM3 driving simulation scenario

    10. Road edge excursions (count) [Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)]

      Count of road edge excursions during a custom STISIM3 driving simulation scenario

    11. Total Collisions (count) [Pre-injury baseline]

      Count of collisions during a custom STISIM3 driving simulation scenario

    12. Total Collisions (count) [Day 2]

      Count of collisions during a custom STISIM3 driving simulation scenario

    13. Total Collisions (count) [Day 4]

      Count of collisions during a custom STISIM3 driving simulation scenario

    14. Total Collisions (count) [Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)]

      Count of collisions during a custom STISIM3 driving simulation scenario

    15. Total Collisions (count) [Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)]

      Count of collisions during a custom STISIM3 driving simulation scenario

    16. Standard Deviation of Lane Position (feet) [Pre-injury baseline]

      Variability of lateral lane position during a custom STISIM3 driving simulation scenario

    17. Standard Deviation of Lane Position (feet) [Day 2]

      Variability of lateral lane position during a custom STISIM3 driving simulation scenario

    18. Standard Deviation of Lane Position (feet) [Day 4]

      Variability of lateral lane position during a custom STISIM3 driving simulation scenario

    19. Standard Deviation of Lane Position (feet) [Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)]

      Variability of lateral lane position during a custom STISIM3 driving simulation scenario

    20. Standard Deviation of Lane Position (feet) [Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)]

      Variability of lateral lane position during a custom STISIM3 driving simulation scenario

    21. Standard Deviation of speed (miles per hour) [Pre-injury baseline]

      Variability of driving speed during a custom STISIM3 driving simulation scenario

    22. Standard Deviation of speed (miles per hour) [Day 2]

      Variability of driving speed during a custom STISIM3 driving simulation scenario

    23. Standard Deviation of speed (miles per hour) [Day 4]

      Variability of driving speed during a custom STISIM3 driving simulation scenario

    24. Standard Deviation of speed (miles per hour) [Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)]

      Variability of driving speed during a custom STISIM3 driving simulation scenario

    25. Standard Deviation of speed (miles per hour) [Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)]

      Variability of driving speed during a custom STISIM3 driving simulation scenario

    26. Number of drives per day (count) [Up to 9 days post-injury]

      Total number of drives per day captured as a naturalistic driving outcomes

    27. Distance travelled per day (miles) [Up to 9 days post-injury]

      Total distance driven per day captured as a naturalistic driving outcomes

    28. Drive time per day (minutes) [Up to 9 days post-injury]

      Total drive time per day captured as a naturalistic driving outcomes

    29. Total symptom severity score [Day 2]

      Total sum of 0-6 ratings across 22 symptom items (SCAT6)

    30. Total symptom severity score [Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)]

      Total sum of 0-6 ratings across 22 symptom items (SCAT6)

    31. Total symptom severity score [Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)]

      Total sum of 0-6 ratings across 22 symptom items (SCAT6)

    32. Verbal Memory [Day 2]

      Verbal memory domain score from CNS Vital Signs

    33. Verbal Memory [Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)]

      Verbal memory domain score from CNS Vital Signs

    34. Verbal Memory [Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)]

      Verbal memory domain score from CNS Vital Signs

    35. Visual Memory [Day 2]

      Visual memory domain score from CNS Vital Signs

    36. Visual Memory [Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)]

      Visual memory domain score from CNS Vital Signs

    37. Visual Memory [Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)]

      Visual memory domain score from CNS Vital Signs

    38. Psychomotor Speed [Day 2]

      Psychomotor speed domain score from CNS Vital Signs

    39. Psychomotor Speed [Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)]

      Psychomotor speed domain score from CNS Vital Signs

    40. Psychomotor Speed [Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)]

      Psychomotor speed domain score from CNS Vital Signs

    41. Reaction Time [Day 2]

      Reaction time domain score from CNS Vital Signs

    42. Reaction Time [Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)]

      Reaction time domain score from CNS Vital Signs

    43. Reaction Time [Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)]

      Reaction time domain score from CNS Vital Signs

    44. Complex attention [Day 2]

      Complex attention domain score from CNS Vital Signs

    45. Complex attention [Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)]

      Complex attention domain score from CNS Vital Signs

    46. Complex attention [Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)]

      Complex attention domain score from CNS Vital Signs

    47. Cognitive Flexibility [Day 2]

      Cognitive flexibility domain score from CNS Vital Signs

    48. Cognitive Flexibility [Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)]

      Cognitive flexibility domain score from CNS Vital Signs

    49. Cognitive Flexibility [Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)]

      Cognitive flexibility domain score from CNS Vital Signs

    50. Processing Speed [Day 2]

      Processing speed domain score from CNS Vital Signs

    51. Processing Speed [Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)]

      Processing speed domain score from CNS Vital Signs

    52. Processing Speed [Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)]

      Processing speed domain score from CNS Vital Signs

    53. Executive function [Day 2]

      Executive functions domain score from CNS Vital Signs

    54. Executive function [Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)]

      Executive functions domain score from CNS Vital Signs

    55. Executive function [Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)]

      Executive functions domain score from CNS Vital Signs

    56. Balance Error Scoring System Total Error Score (count) [Day 2]

      Number of errors committed during the Balance Error Scoring System

    57. Balance Error Scoring System Total Error Score (count) [Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)]

      Number of errors committed during the Balance Error Scoring System

    58. Balance Error Scoring System Total Error Score (count) [Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)]

      Number of errors committed during the Balance Error Scoring System

    59. Tandem Gait Time (seconds) [Day 2]

      Seconds to complete the tandem gait task

    60. Tandem Gait Time (seconds) [Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)]

      Seconds to complete the tandem gait task

    61. Tandem Gait Time (seconds) [Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)]

      Seconds to complete the tandem gait task

    62. Smooth Pursuit Symptom Rating [Day 2]

      Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    63. Smooth Pursuit Symptom Rating [Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)]

      Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    64. Smooth Pursuit Symptom Rating [Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)]

      Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    65. Horizontal Saccades Symptom Rating [Day 2]

      Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    66. Horizontal Saccades Symptom Rating [Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)]

      Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    67. Horizontal Saccades Symptom Rating [Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)]

      Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    68. Vertical Saccades Symptom Rating [Day 2]

      Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    69. Vertical Saccades Symptom Rating [Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)]

      Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    70. Vertical Saccades Symptom Rating [Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)]

      Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    71. Convergence Symptom Rating [Day 2]

      Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    72. Convergence Symptom Rating [Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)]

      Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    73. Convergence Symptom Rating [Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)]

      Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    74. Horizontal VOR Symptom Rating [Day 2]

      Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    75. Horizontal VOR Symptom Rating [Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)]

      Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    76. Horizontal VOR Symptom Rating [Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)]

      Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    77. Vertical VOR Symptom Rating [Day 2]

      Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    78. Vertical VOR Symptom Rating [Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)]

      Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    79. Vertical VOR Symptom Rating [Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)]

      Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    80. Visual Motion Sensitivity Symptom Rating [Day 2]

      Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    81. Visual Motion Sensitivity Symptom Rating [Within 24 hours of when symptoms resolve (Asymptomatic) (on average <30 days post-concussion - tracked up to 1 year)]

      Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    82. Visual Motion Sensitivity Symptom Rating [Within 24 hours of unrestricted medical clearance (on average <30 days post-concussion - tracked up to 1 year)]

      Sum of 0-10 ratings across 4 symptom items as part of Vestibulo-Ocular Motor Screening

    Secondary Outcome Measures

    1. Pedestrian Collisions (count) [Pre-injury baseline, day 2, day 4, within 24 hours of when symptoms resolve (Asymptomatic), within 24 hours of unrestricted medical clearance]

      Count of pedestrian collisions during a custom STISIM3 driving simulation scenario

    2. Speed exceedances (count) [Pre-injury baseline, day 2, day 4, within 24 hours of when symptoms resolve (Asymptomatic), within 24 hours of unrestricted medical clearance]

      Count of speed exceedances during a custom STISIM3 driving simulation scenario

    3. Percent time over speed limit (%) [Pre-injury baseline, day 2, day 4, within 24 hours of when symptoms resolve (Asymptomatic), within 24 hours of unrestricted medical clearance]

      Percent time over speed limit during a custom STISIM3 driving simulation scenario

    4. Percent time out of lane (%) [Pre-injury baseline, day 2, day 4, within 24 hours of when symptoms resolve (Asymptomatic), within 24 hours of unrestricted medical clearance]

      Percent time out of lane during a custom STISIM3 driving simulation scenario

    5. Lateral lane position (feet) [Pre-injury baseline, day 2, day 4, within 24 hours of when symptoms resolve (Asymptomatic), within 24 hours of unrestricted medical clearance]

      Lateral lane position during a custom STISIM3 driving simulation scenario

    6. Speed (miles per hour) [Pre-injury baseline, day 2, day 4, within 24 hours of when symptoms resolve (Asymptomatic), within 24 hours of unrestricted medical clearance]

      Driving speed during a custom STISIM3 driving simulation scenario

    7. Number of speeding events (count) [Up to 9 days post-injury]

      Number of speeding events captured as a naturalistic driving outcomes

    8. Hard braking events (count) [Up to 9 days post-injury]

      Hard braking events captured as a naturalistic driving outcomes

    9. Hard acceleration events (count) [Up to 9 days post-injury]

      Hard acceleration events captured as a naturalistic driving outcomes

    10. Hard cornering events (count) [Up to 9 days post-injury]

      Hard cornering events captured as a naturalistic driving outcomes

    11. UFOV Processing Speed (ms) [Day 2, within 24 hours of when symptoms resolve (Asymptomatic), within 24 hours of unrestricted medical clearance]

      Processing Speed task performance during Useful Field of View Test

    12. UFOV Divided Attention (ms) [Day 2, within 24 hours of when symptoms resolve (Asymptomatic), within 24 hours of unrestricted medical clearance]

      Divided attention task performance during Useful Field of View Test

    13. UFOV Selective Attention (ms) [Day 2, within 24 hours of when symptoms resolve (Asymptomatic), within 24 hours of unrestricted medical clearance]

      Selective attention task performance during Useful Field of View Test

    14. Rey Osterrieth Copy Score (count) [Day 2, within 24 hours of when symptoms resolve (Asymptomatic), within 24 hours of unrestricted medical clearance]

      Number of correct items when drawing figure during a Rey Osterrieth copy trial

    15. Rey Osterrieth Copy Time (sec) [Day 2, within 24 hours of when symptoms resolve (Asymptomatic), within 24 hours of unrestricted medical clearance]

      Time to draw a figure during a Rey Osterrieth copy trial

    Other Outcome Measures

    1. Stop light tickets (count) [Pre-injury baseline, day 2, day 4, within 24 hours of when symptoms resolve (Asymptomatic), within 24 hours of unrestricted medical clearance]

      Count of stop light tickets during a custom STISIM3 driving simulation scenario

    2. Stop sign tickets (count) [Pre-injury baseline, day 2, day 4, within 24 hours of when symptoms resolve (Asymptomatic), within 24 hours of unrestricted medical clearance]

      Count of stop sign tickets during a custom STISIM3 driving simulation scenario

    3. Turn signal use (count) [Pre-injury baseline, day 2, day 4, within 24 hours of when symptoms resolve (Asymptomatic), within 24 hours of unrestricted medical clearance]

      Count of turn signal use during a custom STISIM3 driving simulation scenario

    4. Tailgating (count) [Pre-injury baseline, day 2, day 4, within 24 hours of when symptoms resolve (Asymptomatic), within 24 hours of unrestricted medical clearance]

      Count of tailgating events during a custom STISIM3 driving simulation scenario

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • 18 years old or older

    • Possesses a valid driver's license

    • 1 year or more of driving experience

    • Normal or corrected-to-normal vision

    • Rostered on an organized athletic team at the college level

    • (Concussion Group Only) Diagnosed with concussion by a physician and meet inclusion criteria above.

    Exclusion Criteria:
    • Four or more previous concussions

    • A concussion within the past 6 months

    • History of any major neurological disorders or injuries

    • Current use of any medications that evoke drowsiness (prescription or over the counter)

    • Current orthopedic condition that interferes with driving (e.g. a walking boot, shoulder immobilizer)

    • Heavy use of alcohol (binge drinking 5+ days in the past 30 days)

    • Any illegal drug use (any illegal substance use)

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • University of Georgia
    • Emory University
    • University of Kansas
    • Shepherd Center, Atlanta GA

    Investigators

    • Principal Investigator: Julianne Schmidt, PhD, ATC, University of Georgia

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Julianne Schmidt, Associate Professor, University of Georgia
    ClinicalTrials.gov Identifier:
    NCT05942638
    Other Study ID Numbers:
    • PROJECT00007249
    First Posted:
    Jul 12, 2023
    Last Update Posted:
    Jul 12, 2023
    Last Verified:
    Jul 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 12, 2023